Progyny Inc is a benefits management company that specializes in providing fertility and family-building benefits to employers and their employees. The company aims to improve the employee experience through comprehensive fertility solutions, including in vitro fertilization (IVF), egg freezing, and adoption services. Progyny partners with a network of fertility specialists to offer personalized care and support, helping individuals and couples navigate their family-building journeys. By focusing on innovative health services and a tailored approach, Progyny enhances the overall health and well-being of families while also addressing the financial implications of fertility treatments for employers. Read More
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s revenue was optimistic at $297.5 million at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.48 per share was 12.1% above analysts’ consensus estimates.
Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member Engagement
The Caviar Cruise strategy identifies high-quality stocks like Progyny Inc (PGNY), excelling in revenue growth, ROIC, profit quality, and debt-free stability for long-term investors.
Increased awareness of expanded women’s health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings
Shares of fertility benefits company Progyny (NASDAQ:PGNY)
jumped 3.1% in the afternoon session after the stock gained ground amid a broader market rally as investors looked ahead to a busy week of corporate earnings reports.
Shares of fertility benefits company Progyny (NASDAQ:PGNY)
fell 3.9% in the afternoon session after a regulatory filing revealed a significant institutional investor had sharply reduced its stake in the company.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new partnership with ŌURA, maker of the world’s leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges.
However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Through Amazon’s Health Benefits Connector, eligible individuals can now seamlessly enroll in Progyny benefits that are available to them through their employer or health plan.
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry has tumbled by 7.5%. This drop was disheartening since the S&P 500 held its ground.
Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Progyny (NASDAQ:PGNY) and its peers.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
